508 related articles for article (PubMed ID: 12209700)
1. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
Yan P; Coindre JM; Benhattar J; Bosman FT; Guillou L
Cancer Res; 1999 Jul; 59(13):3166-70. PubMed ID: 10397260
[TBL] [Abstract][Full Text] [Related]
3. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity and hTERT mRNA expression in body fluids.
Yamamoto Y; Hirakawa E
Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
9. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
10. Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
Schrader M; Burger AM; Müller M; Krause H; Straub B; Smith GL; Newlands ES; Miller K
Oncol Rep; 2002; 9(5):1097-105. PubMed ID: 12168080
[TBL] [Abstract][Full Text] [Related]
11. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
[TBL] [Abstract][Full Text] [Related]
13. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
14. Expression of telomerase genes in thyroid carcinoma.
Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
[TBL] [Abstract][Full Text] [Related]
15. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
[TBL] [Abstract][Full Text] [Related]
16. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.
Bièche I; Noguès C; Paradis V; Olivi M; Bedossa P; Lidereau R; Vidaud M
Clin Cancer Res; 2000 Feb; 6(2):452-9. PubMed ID: 10690523
[TBL] [Abstract][Full Text] [Related]
19. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
20. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]